TCA cycle metabolic compromise due to an aberrant S-nitrosoproteome in HIV-associated neurocognitive disorder with methamphetamine use.
Paschalis-Thomas DouliasTomohiro NakamuraHenry ScottScott R McKercherAbdullah SultanAmanda DealMatthew AlbertolleHarry IschiropoulosStuart A LiptonPublished in: Journal of neurovirology (2021)
In the brain, both HIV-1 and methamphetamine (meth) use result in increases in oxidative and nitrosative stress. This redox stress is thought to contribute to the pathogenesis of HIV-associated neurocognitive disorder (HAND) and further worsening cognitive activity in the setting of drug abuse. One consequence of such redox stress is aberrant protein S-nitrosylation, derived from nitric oxide, which may disrupt normal protein activity. Here, we report an improved, mass spectrometry-based technique to assess S-nitrosylated protein in human postmortem brains using selective enrichment of S-nitrosocysteine residues with an organomercury resin. The data show increasing S-nitrosylation of tricarboxylic acid (TCA) enzymes in the setting of HAND and HAND/meth use compared with HIV+ control brains without CNS pathology. The consequence is systematic inhibition of multiple TCA cycle enzymes, resulting in energy collapse that can contribute to the neuronal and synaptic damage observed in HAND and meth use.
Keyphrases
- antiretroviral therapy
- hiv positive
- hiv infected
- hiv testing
- human immunodeficiency virus
- hepatitis c virus
- hiv aids
- men who have sex with men
- nitric oxide
- mass spectrometry
- south africa
- bipolar disorder
- protein protein
- amino acid
- endothelial cells
- binding protein
- white matter
- emergency department
- oxidative stress
- multiple sclerosis
- high resolution
- stress induced
- brain injury
- hydrogen peroxide
- machine learning
- electron transfer
- ms ms
- capillary electrophoresis